Literature DB >> 3981034

Mast cell depletion in murine chronic graft-versus-host disease.

H N Claman.   

Abstract

A murine model of chronic graft-versus-host disease (GVHD) was induced across minor histocompatibility barriers. This was done by injecting B10.D2 (H-2d) spleen cells into irradiated BALB/c (H-2d) mice. Chronic GVHD in this model includes features common to human idiopathic scleroderma, such as dermal fibrosis, loss of dermal fat and appendages, and a mononuclear cell filtrate. Serial skin biopsies showed a progressive loss of stainable mast cells in GVHD but not in irradiated controls. Mast cell depletion was noted as well in the tongue and kidney capsule of GVHD mice. Mast cell depletion was noted as early as 11 days after GVHD induction and persisted for at least 56 days. A hypothesis is put forth linking the T-cell activation of GVHD, mast cell degranulation, and increased fibrosis. The pertinence of this hypothesis to idiopathic scleroderma is pointed out.

Entities:  

Mesh:

Year:  1985        PMID: 3981034     DOI: 10.1111/1523-1747.ep12265302

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).

Authors:  R M Silver; A Ludwicka; M Hampton; T Ohba; S A Bingel; T Smith; R A Harley; J Maize; M P Heyes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

2.  Anti-IgE autoantibodies in systemic sclerosis (scleroderma).

Authors:  L D Kaufman; B L Gruber; M J Marchese; J R Seibold
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

3.  Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells.

Authors:  Dennis B Leveson-Gower; Emanuela I Sega; Janet Kalesnikoff; Mareike Florek; Yuqiong Pan; Antonio Pierini; Stephen J Galli; Robert S Negrin
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

4.  Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.

Authors:  A Nagler; V Segal; S Slavin; F Levi-Schaffer
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

5.  Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease.

Authors:  Ethan Strattan; Senthilnathan Palaniyandi; Reena Kumari; Jing Du; Natalya Hakim; Timothy Huang; Melissa V Kesler; C Darrell Jennings; Jamie L Sturgill; Gerhard C Hildebrandt
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 6.  A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis.

Authors:  Traci A Wilgus; Sara Ud-Din; Ardeshir Bayat
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

Review 7.  Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease.

Authors:  Ethan Strattan; Gerhard Carl Hildebrandt
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.